Hims & Hers Health Faces Securities Class Action Investigation

Strategic Insights -

Faruqi & Faruqi, LLP is investigating claims against Hims & Hers Health, Inc. (HIMS) for allegedly making false and/or misleading statements and/or failing to disclose that the company was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy." This led to a substantial risk that the company's collaboration with Novo Nordisk would be terminated, and the partnership was eventually ended on June 23, 2025.

The court-appointed lead plaintiff is seeking to represent the class and direct the litigation. Investors who suffered losses exceeding $50,000 in Hims between April 29, 2025, and June 22, 2025, are encouraged to contact Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Key Takeaways:

  • Faruqi & Faruqi, LLP is investigating Hims & Hers Health, Inc. for allegedly engaging in deceptive promotion and selling of illegitimate versions of Wegovy.
  • The company allegedly failed to disclose this information, putting the partnership with Novo Nordisk at risk.
  • Novo Nordisk ended the partnership on June 23, 2025, due to Hims' alleged failure to adhere to the law and put patient safety at risk.
  • Hims' stock price fell $22.24, or 34.6%, to close at $41.98 per share on June 23, 2025.
  • Investors who suffered losses exceeding $50,000 in Hims between April 29, 2025, and June 22, 2025, are encouraged to contact Faruqi & Faruqi partner Josh Wilson directly.
  • The court-appointed lead plaintiff is seeking to represent the class and direct the litigation.
  • Any member of the putative class can move the Court to serve as lead plaintiff through counsel of their choice.

Statistics:

  • Hims' stock price fell $22.24, or 34.6%, to close at $41.98 per share on June 23, 2025.
  • The partnership between Hims and Novo Nordisk was ended on June 23, 2025.
  • Investors who suffered losses exceeding $50,000 in Hims between April 29, 2025, and June 22, 2025, are encouraged to contact Faruqi & Faruqi partner Josh Wilson directly.

Sources:

  • Newsfile Corp. - August 19, 2025
  • www.faruqilaw.com